Department of Internal Medicine, Mount Sinai Hospital, Chicago, IL, USA.
Department of Internal Medicine, Jibjibe Primary Health Care Center, Rasuwa, Nepal.
J Interv Card Electrophysiol. 2024 Oct;67(7):1679-1690. doi: 10.1007/s10840-023-01656-z. Epub 2023 Sep 29.
Pulmonary vein isolation (PVI) is the cornerstone of catheter ablation of atrial fibrillation (AF); however, the results are suboptimal for persistent AF. The left atrial posterior wall (LAPW) is thought to be a major additional area in initiation and perpetuation of persistent AF. Therefore, adjunctive ablation of the posterior wall may reduce AF recurrence in patients with persistent AF.
The objective of this study was to compare outcomes of catheter ablation in patients with persistent AF using PVI alone versus a combination of PVI and LAPW isolation.
Literature search was conducted in PubMed, PubMed Central, Scopus, and Embase since inception to February 2023. Screening of studies was done via Covidence software. Risk of bias assessment was done using appropriate tools. Data extraction and a narrative synthesis were carried out accordingly.
Ten studies were included, of which five were randomized controlled trials. PVI with LAPW ablation group had significantly lower recurrence of overall atrial tachyarrhythmia (OR 0.47, CI 0.32-0.70) and AF (OR 0.39, CI 0.23-0.69). In sensitivity analysis, freedom from atrial arrhythmias was noted to be significantly higher in the PVI with LAPW ablation group (OR 2.22, CI 1.36-3.64). However, there was no significant difference in occurrence of atrial flutter (OR 1.36, CI 0.86-2.14) or with periprocedural adverse events (OR 1.10, CI 0.60-1.99).
LAPW ablation, in addition to PVI, significantly improves the rates of arrhythmia freedom and reduces the recurrence of overall atrial tachyarrhythmia. There was no significant difference in atrial flutter or periprocedural adverse events.
肺静脉隔离(PVI)是导管消融治疗心房颤动(AF)的基石;然而,对于持续性 AF 的治疗效果并不理想。左心房后壁(LAPW)被认为是持续性 AF 起始和维持的主要附加区域。因此,附加消融后壁可能会降低持续性 AF 患者的 AF 复发率。
本研究旨在比较单独行 PVI 与 PVI 联合 LAPW 隔离治疗持续性 AF 患者的消融结果。
从建库至 2023 年 2 月,在 PubMed、PubMed Central、Scopus 和 Embase 中进行文献检索。通过 Covidence 软件进行研究筛选。使用适当的工具进行偏倚风险评估。相应地进行数据提取和叙述性综合。
纳入了 10 项研究,其中 5 项为随机对照试验。LAPW 消融联合 PVI 组的总体房性快速性心律失常(OR 0.47,95%CI 0.32-0.70)和 AF(OR 0.39,95%CI 0.23-0.69)的复发率显著降低。敏感性分析表明,LAPW 消融联合 PVI 组的无房性心律失常率显著更高(OR 2.22,95%CI 1.36-3.64)。然而,房性扑动(OR 1.36,95%CI 0.86-2.14)或围手术期不良事件(OR 1.10,95%CI 0.60-1.99)的发生率无显著差异。
除 PVI 外,LAPW 消融可显著提高心律失常的无复发率,降低总体房性快速性心律失常的复发率。房性扑动或围手术期不良事件无显著差异。